Effects of topical pimecrolimus on skin histology, inflammatory infiltrate and cytokine production in atopic dermatitis

被引：0
|
作者：
Simon, D
Vassina, E
Braathen, LR
Simon, HU
机构：
[1] Univ Bern, Dept Dermatol, CH-3012 Bern, Switzerland
[2] Univ Bern, Dept Pharmacol, CH-3012 Bern, Switzerland
来源：
PHARMACOLOGY | 2004年 / 72卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：148 / 148
页数：1
相关论文
共 50 条
  • [41] MACROPHAGE DIFFERENTIATION AND CYTOKINE PRODUCTION IN ATOPIC-DERMATITIS
    BANERJEE, P
    XU, XJ
    POULTER, LW
    RUSTIN, M
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1995, 104 (04) : 683 - 683
  • [42] Cytokine production, activation marker, and skin homing receptor in children with atopic dermatitis and bronchial asthma
    Antúnez, C
    Torres, MJ
    Mayorga, C
    Corzo, JL
    Jurado, A
    Santamaría-Babi, LF
    Vera, A
    Blanca, M
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2006, 17 (03) : 166 - 174
  • [43] Inflammatory cytokine mediated induction of serine racemase in atopic dermatitis
    Yoshihisa, Yoko
    Nakagawa, Maho
    Rehman, Mati Ur
    Makino, Teruhiko
    Mori, Hisashi
    Shimizu, Tadamichi
    CYTOKINE, 2017, 100 : 88 - 88
  • [44] Cancer Risk With Topical Pimecrolimus and Tacrolimus For Atopic Dermatitis: Systematic Review and Bayesian Meta-Analysis
    Chu, Alexandro
    Devasenapathy, Niveditha
    Wong, Melanie
    Srivastava, Archita
    Lin, Clement
    Ceccacci, Renata
    Mac-Donald, Margaret
    Chu, Derek
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB192 - AB192
  • [45] Inflammatory cytokine mediated induction of serine racemase in atopic dermatitis
    Yoshihisa, Y.
    Nakagawa, M.
    Rehman, M.
    Matsukuma, S.
    Makino, T.
    Mori, H.
    Shimizu, T.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (10) : S263 - S263
  • [46] Atopic dermatitis: immunophenotyping of inflammatory cells in skin lesions
    Lugovic, L
    Lipozenocic, J
    Jakic-Razumovic, J
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2001, 40 (08) : 489 - 494
  • [47] The effects of pimecrolimus cream 1% on key physiology parameters in patients with atopic dermatitis
    Aschoff, R.
    Schwanebeck, U.
    Braeutigam, M.
    Meurer, N.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2008, 128 : S102 - S102
  • [48] CANCER RISK WITH TOPICAL PIMECROLIMUS AND TACROLIMUS FOR ATOPIC DERMATITIS: SYSTEMATIC REVIEW AND BAYESIAN META-ANALYSIS
    Chu, A.
    Devasenapathy, N.
    Wong, M.
    Srivastava, A.
    Ceccacci, R.
    Lin, C.
    Chu, D.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 129 : S7 - S7
  • [49] Combination of low-dosage cyclosporine and topical pimecrolimus in severe atopic dermatitis with chronic hepatitis B
    Campione, Elena
    Paterno, Evelin Jasmine
    Diluvio, Laura
    Bianchi, Luca
    Giorgetti, Giammarco
    Chimenti, Sergio
    ACTA DERMATO-VENEREOLOGICA, 2008, 88 (01) : 74 - 75
  • [50] StabiEL:: Stabilization of skin condition with Elidel -: a patients' satisfaction observational study addressing the treatment, with pimecrolimus cream, of atopic dermatitis pretreated with topical corticosteroid
    Gollnick, Harald
    Luger, Thomas
    Freytag, Siegfried
    Braeutigam, Matthias
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2008, 22 (11) : 1319 - 1325
12345